Apple cider vinegar effervescent tablets on gut health, obesity and user experience – A randomized controlled trial

Abstract

Research indicates that apple cider vinegar (ACV) may benefit health by lowering blood glucose, cholesterol, triglycerides, body weight, waist circumference, and BMI. To investigate further, a 60-day randomized controlled trial was conducted at Sudha Institute of Medical Science involving 77 participants with abnormal weight. They were divided into control and ACV groups. The ACV group consumed a daily ACV effervescent tablet, engaged in mild exercise, and followed a low-sugar diet, while the control group followed only the exercise and diet regimen. Anthropometric measurements and participant satisfaction data were collected throughout. The analysis revealed significant reductions in weight, BMI, waist and hip circumference, and waist-hip ratio over the 60-day period. Additionally, improvements were observed in abnormal food intake and various digestive issues such as appetite, constipation, cravings, and gas problems in the ACV group. Notably, 56.25% of control group participants and 44.44% of ACV group participants were categorized as overweight. Data analysis was conducted using Microsoft Excel, utilizing descriptive statistics such as mean and percentage. The study concluded that daily consumption of ACV effervescent tablets has a positive impact on weight loss and alleviates issues related to digestion and appetite. These findings underscore the potential benefits of incorporating ACV into dietary and lifestyle interventions for individuals with abnormal weight, suggesting its role as a complementary approach to promote overall health and well-being.